Glucosamine Plus
Natural health product licensed in Canada
- Licence holder
- Nutragenius Inc.
- NPN or DIN-HM
- 80088813
- Status
- Inactive licence
- Licence date
- 19 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Vitis vinifera Source : Graine(s) Potency : 85 % Oligomeric proanthocyanidins | 30 mg |
| Sulfate de chondroïtine Source : Chondroitin sulfate sodium obtained from avian cartilage | 200 mg |
| Vitamine C Source : Acide ascorbique | 30 mg |
| L-Lysine Source : Acétate de L-lysine | 40 mg |
Non-medicinal ingredients
Hypromellose, Chlorophylle, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in collagen formation. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. Source of antioxidants for the maintenance of good health. Helps in the development and maintenance of bones. Helps in the development and maintenance of cartilage. Helps in connective tissue formation. Helps in wound healing.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80088813
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.